Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose versus placebo in chronic heart failure with iron deficiency
2006-004608-37Phase 3Completed
- Sponsor
- Vifor Pharma
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) and chronic heart failure (CHF) comparing Ferinject with Placebo (2 arms). Primary endpoints: Self-reported patient global assessment score and Change in NYHA class from baseline. Started Mar 2007; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2006-004608-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004608-37.